22 OCTOBER 2026 ASX RELEASE AMPLIA THERAPEUTICS PROVIDES CLINICAL TRIAL UPDATES HIGHLIGHTS • One patient remains on the ACCENT trial, with 2 patients completing 24 months on study • One patient remains on the AMPLICITY trial with 1 confirmed and 1 unconfirmed partial response (PR) recorded to...